Clinical Trial Update: Efficacy Study of Nitazoxanide Suspension in the Treatment of Rotavirus Disease in Children [Phase 2]

View source ↗

Summary

A Phase 2 efficacy study of nitazoxanide suspension for rotavirus disease in children has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotavirus Infection
• Viral Gastroenteritis Due to Rotavirus

Drugs mentioned

• Nitazoxanide Suspension (nitazoxanide)

Snippet

Sponsor: Romark Laboratories L.C. | Conditions: Rotavirus Infection, Viral Gastroenteritis Due to Rotavirus | Phase 2 | Status: COMPLETED